Scientific article
English

A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk

Published inBritish Journal of Clinical Pharmacology, vol. 86, no. 8, p. 1642-1653
Publication date2020
Abstract

Escitalopram (SCIT) is frequently prescribed to breastfeeding women. Available information on SCIT excretion into breast milk is based on heterogeneous and incomplete data. A population pharmacokinetic model that aimed to better characterize maternal and infant exposure to SCIT and its metabolite was developed.

Keywords
  • Animals
  • Breast Feeding
  • Citalopram/pharmacokinetics
  • Female
  • Humans
  • Infant
  • Milk
  • Human/metabolism
  • Pharmaceutical Preparations
  • Pregnancy
  • Prospective Studies
  • Serotonin Uptake Inhibitors/pharmacokinetics
Citation (ISO format)
WEISSKOPF, Etienne et al. A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk. In: British Journal of Clinical Pharmacology, 2020, vol. 86, n° 8, p. 1642–1653. doi: 10.1111/bcp.14278
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0306-5251
390views
2downloads

Technical informations

Creation26/07/2021 10:01:00
First validation26/07/2021 10:01:00
Update time16/03/2023 01:32:37
Status update16/03/2023 01:32:36
Last indexation31/10/2024 23:25:37
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack